FIRST REPORT ON OTOTOXICITY OF MEGLUMINE ANTIMONIATE

Introduction: Pentavalent antimonials are the first drug of choice in the treatment of tegumentary leishmaniasis. Data on ototoxicity related with such drugs is scarcely available in literature, leading us to develop a study on cochleovestibular functions. Case Report: A case of a tegumentary leishm...

Full description

Bibliographic Details
Published in:Revista do Instituto de Medicina Tropical de São Paulo
Main Authors: Cláudia Maria Valete-Rosalino, Maria Helena Araujo-Melo, Débora Cristina de Oliveira Bezerra, Renata Oliveira de Barcelos, Vanessa de Melo-Ferreira, Tânia Salgado de Sousa Torraca, Ana Cristina da Costa Martins, João Soares Moreira, Mirian Catherine Melgares Vargas, Frederico Pereira Bom Braga, Mariza de Matos Salgueiro, Maurício Naoto Saheki, Armando Oliveira Schubach
Format: Article in Journal/Newspaper
Language:English
Published: Universidade de São Paulo (USP) 2014
Subjects:
Online Access:https://doi.org/10.1590/S0036-46652014000500012
https://doaj.org/article/01ac345408fb4ed6a41bdaccd7d6bdb9
Description
Summary:Introduction: Pentavalent antimonials are the first drug of choice in the treatment of tegumentary leishmaniasis. Data on ototoxicity related with such drugs is scarcely available in literature, leading us to develop a study on cochleovestibular functions. Case Report: A case of a tegumentary leishmaniasis patient, a 78-year-old man who presented a substantial increase in auditory threshold with tinnitus and severe rotatory dizziness during the treatment with meglumine antimoniate, is reported. These symptoms worsened in two weeks after treatment was interrupted. Conclusion: Dizziness and tinnitus had already been related to meglumine antimoniate. However, this is the first well documented case of cochlear-vestibular toxicity related to meglumine antimoniate.